Correlation Engine 2.0
Clear Search sequence regions


  • brain (1)
  • cells (4)
  • cellular (1)
  • cerebellar cortex (1)
  • fibroblasts (3)
  • knockout mice (2)
  • MCT8 (10)
  • neuroblastoma (1)
  • Oatp1c1 (1)
  • patients (4)
  • Pax8 (1)
  • plasma membrane (1)
  • serum (1)
  • TA3 (11)
  • transports (4)
  • triac (1)
  • vitro (2)
  • Sizes of these terms reflect their relevance to your search.

    MCT8 transports thyroid hormone (TH) across the plasma membrane. Mutations in MCT8 result in the Allan-Herndon-Dudley syndrome (AHDS), comprising severe psychomotor retardation and elevated serum T3 levels. As the neurological symptoms are most likely caused by a lack of TH transport into the CNS, the administration of a TH analogue which does not require MCT8 for cellular uptake may represent a therapeutic strategy. Here, we investigated the therapeutic potential of the biologically active T3 metabolite Triac (TA3) by studying TA3 transport, metabolism and action both in vitro and in vivo. Incubation of SH-SY5Y neuroblastoma cells and MO3.13 oligodendrocytes with labeled substrates showed a time-dependent uptake of T3 and TA3. In intact SH-SY5Y cells, both T3 and TA3 were degraded by endogenous type 3 deiodinase, and they influenced gene expression to a similar extent. Fibroblasts from MCT8 patients showed an impaired T3 uptake compared to controls, whereas TA3 uptake was similar in patient and control fibroblasts. In transfected cells, TA3 did not show significant transport by MCT8. Most importantly, treatment of athyroid Pax8 knockout mice and Mct8/Oatp1c1 double knockout mice between postnatal day 1 and 12 with TA3 restored T3-dependent neural differentiation in the cerebral and cerebellar cortex indicating that TA3 can replace T3 in promoting brain development. In conclusion, we demonstrated uptake of TA3 in neuronal cells and in fibroblasts of MCT8 patients, and similar gene responses to T3 and TA3. This indicates that TA3 bypasses MCT8 and may be used to improve the neural status of MCT8 patients.

    Citation

    Simone Kersseboom, Sigrun Horn, W Edward Visser, Jiesi Chen, Edith C H Friesema, Catherine Vaurs-Barrière, Robin P Peeters, Heike Heuer, Theo J Visser. In vitro and mouse studies support therapeutic utility of triiodothyroacetic acid in MCT8 deficiency. Molecular endocrinology (Baltimore, Md.). 2015 Jan 7:me00009999


    PMID: 25565257

    View Full Text